Bacteraemic pneumococcal pneumonia in COPD patients: better outcomes than expected
- 10 April 2009
- journal article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 28 (8) , 971-976
Abstract
The purpose of the study was to compare the clinical characteristics and outcomes of bacteraemic pneumococcal pneumonia (BPP) in chronic obstructive pulmonary disease (COPD) and non-COPD patients. A case-control study was conducted. Cases were any adult with BPP and forced expiratory volume in 1 second (FEV1) 1/forced expiratory vital capacity (FVC) p = 0.02). In univariate analysis, shock, multilobar involvement, Charlson score, heart failure and absence of COPD were associated with mortality. After adjustment for the presence of shock there were no differences in mortality. BPP presents less frequently with shock and has a lower mortality rate in COPD patients than in non-COPD patients.Keywords
This publication has 33 references indexed in Scilit:
- Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2007
- COPD is associated with increased mortality in patients with community-acquired pneumoniaEuropean Respiratory Journal, 2006
- Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumoniaEuropean Respiratory Journal, 2006
- Impact of initial antibiotic choice on mortality from pneumococcal pneumoniaEuropean Respiratory Journal, 2006
- Epidemiology of community-acquired pneumonia in adult patients at the dawn of the 21st century: a prospective study on the Mediterranean coast of SpainClinical Microbiology and Infection, 2005
- Streptococcus pneumoniae Bacteremia in Patients With CancerMedicine, 2005
- Host-Pathogen Interaction during Pneumococcal Infection in Patients with Chronic Obstructive Pulmonary DiseaseInfection and Immunity, 2004
- An International Prospective Study of Pneumococcal Bacteremia: Correlation with In Vitro Resistance, Antibiotics Administered, and Clinical OutcomeClinical Infectious Diseases, 2003
- Lung infections bullet 5: Streptococcus pneumoniaeThorax, 1999
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987